Protein formulation, preparation method therefor and use thereof

AU2022438138B2Pending Publication Date: 2026-07-23BEIJING LIANGYUAN BIO-SCI LLC
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
AU2022438138
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-01-27
Filing Date
2022-10-27
Publication Date
2026-07-23

Smart Images

  • Figure 00000001_0000
    Figure 00000001_0000
  • Figure 00000001_0001
    Figure 00000001_0001
  • Figure 00000037_0000
    Figure 00000037_0000
Patent Text Reader

Abstract

The present invention relates to a protein formulation, a preparation method therefor and a use thereof. The formulation is an aqueous solvent, and comprises: (1) a cytokine protein having a concentration of greater than 1 mg / ml; (2) poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE); and (3) an essential pH regulator / buffer. The cytokine includes but is not limited to: IL2, IL4, IL7, IL9, IL10, IL15, IL21, G-CSF, GM-CSF, IFN, EPO, GF, and TNF. The formulation is used for preparing drugs or formulations administered by means of subcutaneous injection.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Materials and methods for making improved micelle compositions

    US20050025819A1